Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia.


Por: Cuadros M, Andrades Á, Coira IF, Baliñas C, Rodríguez MI, Álvarez-Pérez JC, Peinado P, Arenas AM, García DJ, Jiménez P, Camós-Guijosa M, Jiménez-Velasco A and Medina PP

Publicada: 25 nov 2019 Ahead of Print: 25 nov 2019
Resumen:


Filiaciones:
Cuadros M:
 Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain

 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Health Research Institute of Granada (ibs.Granada), Granada, Spain

Andrades Á:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Coira IF:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Baliñas C:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Rodríguez MI:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Health Research Institute of Granada (ibs.Granada), Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Álvarez-Pérez JC:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Health Research Institute of Granada (ibs.Granada), Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Peinado P:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

Arenas AM:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain

García DJ:
 Department of Biochemistry and Molecular Biology III and Immunology, University of Granada, Granada, Spain

 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain

Jiménez P:
 Health Research Institute of Granada (ibs.Granada), Granada, Spain

 Department of Clinical Analysis and Immunology, UGC Laboratorio Clínico, University Hospital Virgen de las Nieves, Granada, Spain

Camós-Guijosa M:
 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

 Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, University of Barcelona

 Institut de Recerca Hospital Sant Joan de Deu Barcelona

Jiménez-Velasco A:
 Hematology Laboratory, Universitary Regional Hospital, Málaga, Spain

Medina PP:
 GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.

 Health Research Institute of Granada (ibs.Granada), Granada, Spain.

 Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
ISSN: 20445385





Blood Cancer Journal
Editorial
SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Letter
Volumen: 9 Número: 12
Páginas: 93-93
WOS Id: 000499735500001
ID de PubMed: 31767830
imagen Green Published, gold

MÉTRICAS